Efficacy of reduced dose BCG treatment in response to production shortages. #ExpertCommentary. @FaltasLab @WCMEnglanderIPM discusses work by Lobo et al. in @BJUIjournal. #ReadNow on UroToday > https://bit.ly/3VU45Gg
Calling urologists in Hong Kong!
BJUI Compass publisher @WileyHealth announces their first #OpenAccess agreement in HK
@HKUniversity @hkbaptistu @CUHKMedicine @jteoh_hk @peggychu10
Wiley’s First Open Access Agreement in Hong Kong Promotes Research Accessibility
HOBOKEN, N.J. – January 16, 2023 – Wiley , one of the world’s largest publishers and a global leader i...
Just published online in @BJUIjournal - in focus groups we spoke to patients about their experiences of follow-up after kidney cancer surgery, and used this to form a set of recommendations for best practise care. https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.15982?af=R
Stay up to date with the latest modules published on @bjuiknowledge in January. #Urology #LUTS #UrogenitalInfections #ProstateCancer
Wonderful synergy and intellectual capital at this strategic meeting to propel @BJUIjournal to further heights. Great friendships and meaningful experience being on this board. 🙏 @Freddie_Hamdy @BJUIjournal @WileyGlobal @UTMBUrology @UTMBProvost https://twitter.com/SWilliams_MD/status/1618529262377766912
Arrived day early in Oxford for @BJUIjournal editorial board strategy meeting. No better place/group to go down the rabbit hole! ‘Culture eats strategy for breakfast’-Peter Drucker 🙏 @Freddie_Hamdy @BJUIjournal @WileyGlobal for the invite! @UniofOxford @UTMBUrology @utmbhealth
Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non-muscle-invasive #BladderCancer: A comparative study from experienced institutes
Urolink: 20 Years On
Read all 14 articles about Urolink's activity in sub-Saharan Africa in this free collection of the article series published in 2022
@ncampain @DrKScotland @DocRuMac @MrPeterAndre @MabediCharles @SuzieVenn @shekharbiyani
Online now: Serum testosterone and #ProstateCancer in men with germline BRCA1/2 pathogenic variants
Wonderful BJUI Editorial Team meeting led by our amazing Editor-in-Chief—Prof. Freddie C. Hamdy—taking BJUI to the next level!✨@BJUIjournal @WileyGlobal @Freddie_Hamdy @sophiaanderton @grantissimus @LambAlastair @dr_coops @lawrentschuk @OstherPalle @SWilliams_MD @bwturney et al.